Tingyu Xue

Area of research

Biomedical Engineering · Materials Chemistry

Research interest

Research topics from publications: Radiotherapy combined with nano-biomaterials for cancer radio-immunotherapy; A Prussian blue analog as a decorporation agent for the simultaneous removal of cesium and reactive oxygen species; Oxygen‐Vacancy‐Rich Monolayer BiO2−X Nanosheets for Bacterial Sepsis Management via Dual Physically Antibacterial and Chemically Anti‐inflammatory Functions; Ultrasmall calcium-enriched Prussian blue nanozymes promote chronic wound healing by remodeling the wound microenvironment. Representative work: Radiotherapy (RT) plays an important role in tumor therapy due to its noninvasiveness and wide adaptation. In recent years, radiation therapy has been discovered to induce an anti-tumor immune response, which arouses widespread concern among scientists and clinicians. In this review, we highlight recent advances in the applications of nano-biomaterials for radiotherapy-activated immunotherapy. We first discuss the combination of different radiosensitizing nano-biomaterials and immune checkpoint inhibitors to enhance tumor immune response and improve radiotherapy efficacy. Subsequently, various nano-biomaterials-enabled tumor oxygenation strategies are introduced to alleviate the hypoxic tumo study confirms the efficient Cs decorporation capability of CuFe. The fecal cumulative excretion rate of CuFe reaches 69.5%, which is 1.45 times higher than that of PB (48.8%). These findings demonstrate that CuFe exhibits excellent Cs removal performance and ROS scavenging ability, making it an attractive candidate for the treatment of Cs contamination

Looking for a research collaborator?

Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.